A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition
Status:
Unknown status
Trial end date:
2021-03-28
Target enrollment:
Participant gender:
Summary
The investigation is a randomized, double-blind, placebo involved and multi-center clinical
trial. All subjects are assigned to 2 groups, including Oryz-Aspergillus Enzyme and
Pancreatin tablet group (treatment group) and the placebo group (control group). Treatment
group includes 99 subjects, while control group includes 33 subjects. They receive
investigational drug 2 tablets/times, tid, p.o. for 180 days.